The REIT raises full-year guidance after asset sales provide capital for second-half redeployment.
Omega Healthcare Investors revised its 2026 adjusted funds from operations guidance to $3.22-$3.26 per share, up from a prior range. The increase follows proceeds from asset sales, which management plans to redeploy in the latter half of the year.
The company’s Q2 2026 outlook reflects a strategic shift toward broader market exposure beyond skilled nursing facilities. CEO C. Pickett noted this earnings call marked his and CFO Bob Stephenson’s final appearance, signaling a leadership transition.
No immediate market reaction was disclosed in the earnings call summary.